Although HIPAA nominally guarantees an individual's right to access his or her protected health information, several groups and organizations, claiming that HIPAA is inadequate, have put forth declarations of patients' rights to protect and control their own health data. But, says the author of this article, even these measures are too vague. Instead, he proposes a system that would facilitate true and complete control over personal health data, to the point that patients could license access to researchers and others.
The first stent was invented in 1969 by Charles Theodore Dotter, experimenting on canine peripheral arteries.
Despite contemporary management, patients with acute coronary syndrome (ACS) remain at risk of recurrent adverse cardiovascular events.
How can you create your own medical podcasts? How do you distribute them? Why should you even bother?
Patients with schizoaffective disorder who were treated with paliperidone palmitate (as monotherapy and adjunctive therapy) experienced delayed time to relapse and reduced risk of relapse compared to patients treated with placebo.
One of the most uncomfortable consequences of anticancer therapy is the development of oral mucositis.
With a physician shortage looming and patients seeking more access to caregivers and a higher level of service, is a hybrid concierge model the answer?
We developed a set of equations to predict the risk or probability of developing coronary artery disease (CAD) in 10 years among American Indians. The equations are based on the significant risk factors identified in the Strong Heart Study, a longitudinal study of cardiovascular disease in American Indians. The equations can be used in patient education and to evaluate the efficacy of CAD prevention and intervention programs.
Hybrid lung cancer screening programs use a combination of centralized and decentralized services.
We evaluated a multiethnic cohort of subjects with nonrheumatic atrial fibrillation hospitalized over a 6-year period to determine the racial and ethnic differences in the risk of intracranial hemorrhage (ICH) and the effect of warfarin treatment on ICH risk. Treatment with warfarin was associated with a 2-fold greater risk of ICH in whites, a 4- to 5-fold greater risk in both blacks and Hispanics, and a 15-fold greater risk in Asians. After adjusting for established stroke risk factors and warfarin use, Asians were 4 times as likely as whites to have ICH, whereas blacks and Hispanics were twice as likely.